Antisense Oligonucleotides directed to Ribonucleotide reductase R2 and uses thereof in the treatment of cancer

Details for Australian Patent Application No. 2010202302 (hide)

International Classifications

Event Publications

17 June 2010 Complete Application Filed

24 June 2010 Application Open to Public Inspection

Published as AU-A-2010202302

8 July 2010 Alteration of Name

The name of the applicant has been altered to Lorus Therapeutics Inc.

27 January 2011 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

This application lapsed under section 142(2)(a). A direction to request examination has been given for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.